DOLORS COLOMER at University of Barcelona - Research Interests, Publications & Academic Profile

DOLORS COLOMER

Associate Professor

University of Barcelona

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

30%

Cell Biology

40%

Cancer Biology

80%

Hematology

50%

Leukemia

30%

Next-generation Sequencing

30%

Lymphoma

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications

Article Link

Year:

2024

Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature

Article Link

Year:

2024

Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

Article Link

Year:

2023

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing

Article Link

Year:

2023

Novel Tools for Diagnosis and Monitoring of AML

Article Link

Year:

2023

A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

Article Link

Year:

2022

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

Article Link

Year:

2022

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

Article Link

Year:

2022

EOMES is essential for antitumor activity of CD8<sup>+</sup> T cells in chronic lymphocytic leukemia.

Article Link

Year:

2021

Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery

Article Link

Year:

2021

Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution

Article Link

Year:

2021

Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets

Article Link

Year:

2021

Collaborators5

Nicholas Cross

Professor of Human Genetics

University of Southampton

UNITED KINGDOM

Alex Bataller Torralba

The University of Texas MD Anderson Cancer Center

UNITED STATES

Tobias Roider

University Hospital Heidelberg

GERMANY

Monica Lopez-Guerra

Institut d'Investigacions Biomèdiques de Barcelona

SPAIN

Daniela Zackova

Head physician, consultant

University Hospital Brno

CZECH REPUBLIC

How do Chinese students reach out?

Meet Kite AI